baber/WOPTO huggingface dataset:
Patent FI-850298-A0 (FI)
Inventor: DORN GORDON LEE
IPC: C12Q1/04
Filed: 1985-01-23
Abstract: Methods and compositions are disclosed for the rapid identification of fungal pathogens. In a preferred method, a sample of human body fluid is obtained and subjected to analysis comprising inoculating a nutritive medium, incubating said inoculum for such time and temperature as is necessary for visible fungal colony formation, thereafter plating a sample of said visible fungi on miniature culture plates for example having the dimensions of about 33 x 75 x 5 millimeters, said plates containing differential fungal media, and thereafter indentifying fungal pathogens in a manner consistent with said medium selected. 
<??>In a related method utilizing the differential carbohydrate assimilation properties of fungal pathogens, a sample of human body fluid is obtained and subjected to analysis comprising inoculating a nutritive media, incubating said inoculum for such time and temperature as is necessary for visible fungal colony formation, thereafter inoculating a carbohydrate depleted medium with a sample of said visible fungi, incubating said inoculum for a period of time, thereafter plating a sample of said inoculated carbohydrate depleted medium on miniature culture plates, said plates containing differential carbohydrate assimilation media, and thereafter identifying said fungal pathogens in a manner consistent with said medium selected. 
<??>Novel compositions useful in practicing the disclosed methods are provided. These include an improved fungal growth medium, the improvement comprising the novel addition of ammonium ions to a medium comprising purified saponin, oxgall, a substrate for phenol oxidase and a supporting agent.
Patent FI-873797-A0 (FI)
Inventor: PRADELLE BERNARD
IPC: F04D29/54
Filed: 1987-09-01
Abstract: A blower has a tubular air flow guiding sleeve. An electric motor is located coaxially within the sleeve in a casing connected to the sleeve by flow-straightening blades and a propeller is fixed to a rotary shaft of the motor and placed in front of the blades. A central unit comprises the tubular casing constituting a single casting with the blades and a part of said sleeve surrounding the propeller. A length of that part around the propeller is machined concentrically to an inner surface of said casing slidably receiving the stator of the motor. A PTFE ring may be located in a recess of the sleeve in radial alignment with the propeller blade tips.
Patent FI-882722-A0 (FI)
Inventor: MYLARI BANAVARA LAKSHMANA
IPC: C07D417/06
Filed: 1988-06-08
Abstract: A process for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains comprising reacting an oxophthalizinyl acetic acid ester with an aniline derivative is disclosed. Also disclosed are processes for the preparation of such oxophthalizinyl esters.
Patent FI-883329-A0 (FI)
Inventor: WHITE DANNY R
IPC: C04B35/58
Filed: 1988-07-13
Abstract: Self-supporting bodies are produced by reactive infiltration of a parent metal (10) into boron carbide (12) typically resulting in a composite comprising a boron-containing compound and metal. The mass to be infiltrated may contain one or more inert fillers (14) admixed with the boron carbide (12) to produce a composite by reactive infiltration, which composite comprises a matrix of metal and boron-containing compound embedding the filler (14). The relative amounts of reactants and process conditions may be altered or controlled to yield a body containing varying volume percents of ceramic, metal and/or porosity.
Patent FI-883423-A0 (FI)
Inventor: JOHNSTON DAVID B R
IPC: A61K31/44
Filed: 1988-07-19
Abstract: There are disclosed certain 6-piperazino-purine and heteroaromatic derivatives thereof which have oral hypoglycemic activity and with such ability to lower blood sugar are useful in the treatment of type II diabetes and/or obesity with associated insulin resistance. Processes for the preparation of such compounds and compositions containing such compounds as the active ingredient thereof are also disclosed.
Patent FI-885841-A0 (FI)
Inventor: FAJNER MICHAEL JACOB
IPC: H01H61/01
Filed: 1988-12-16
Abstract: In a plural phase overload relay, a pivot lever (12) is mounted to the ambient compensator deflector (9), and a second pivot lever (34) is mounted to both driver and follower slide bars (36 and 38) and driven thereby to engage and pivot the first lever on the ambient compensator deflector to trip a cut-out switch. The ambient compensator deflector adjusts both the three phase current trip threshold and the loss of phase current trip threshold, and also affords ambient compensator of each. A constant ratio relationship between these two thresholds is provided throughout the entire range of current trip threshold settings. The driver bar moves a first distance for three phase trip and a second shorter distance for loss of phase trip. The ratio of these distances is constant notwithstanding adjustment by the ambient compensator deflector changing the length of such distances.
Patent FI-901290-A0 (FI)
Inventor: MULLER WALTER
IPC: A61M37/00
Filed: 1990-03-15
Abstract: The invention relates to a transdermal system with stepwise medicament release and its use in local or systemic dermal administration of medicaments in human or veterinary medicine or cosmetics.
Patent FI-922268-A0 (FI)
Inventor: ANDERSEN KNUD ERIK
IPC: A61P25/08
Filed: 1992-05-19
Abstract: Novel N-substituted azaheterocyclic carboxylic acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent, the compounds thus having the general formula I <IMAGE> (I)  wherein Y is  <IMAGE>  wherein R1 and R2 independently are C3-8 cycloalkyl phenyl or thienyl all of which may be optionally substituted with halogen, trifluoromethyl, C1-16 alkyl or C1-6 alkoxy; s is 1, 2 or 3; x is -CH2-, -O- or  <IMAGE>  -wherein R3 is hydrogen or C1-6-alkyl; r is 2, 3 or 4; R4 and R5 each represents hydrogen or may together represent a bond and R6 is OH or C1-8-alkoxy; and pharmaceutically acceptable acid addition salts are potent inhibitors of GABA uptake from the synaptic cleft.
Patent FI-933736-A0 (FI)
Inventor: KLIGMAN ALBERT M
IPC: A61K31/165
Filed: 1993-08-25
Abstract: A method for retarding and reversing cellulite comprises topically applying to human skin a retinoid in an amount and for a period of time effective to retard or reverse cellulite where said amount is insufficient to be excessively irritating. The method preferably uses retinoic acid in an emollient vehicle.
Patent FI-943962-A0 (FI)
Inventor: SUEHR SUSAN LYNN
IPC: D04H13/00
Filed: 1994-08-29
Abstract: A non-woven fabric having improved absorbent characteristics. The fabric has three different fiber arrays which are interconnected to produce a unique fiber distribution in the fabric.
Patent FI-950248-A0 (FI)
Inventor: SMITH WILLIAM DAVID
IPC: C07K14/44
Filed: 1995-01-20
Abstract: The present invention provides novel metazoan parasite antigens, nucleic acids encoding them and their use in the control of disease caused by helminth and other metazoan parasites, particularly helminth and arthropod parasites in domestic animals. In particular the invention provides a protective metazoan parasite antigen or antigenic fragments, components or precursors thereof and functionally-equivalent derivatives, analogues or variants thereof having protective antigenic activity against one or more metazoan parasites, which antigen is characterised by being capable of binding to pepstatin, and which in native form is an integral membrane protein or protein complex. Also provided are antigens characterised by aspartyl proteinase-like and/or neutral endopeptidase-like activity.
Patent FI-952541-A0 (FI)
Inventor: CONRAD HANS-ROLF
IPC: F16C13/00
Filed: 1995-05-24
Abstract: The covering (3) has a thermally insulating layer and surrounds a heatable roll (2) partially. The roll (2) is for the treatment of paper webs. The covering reduces heat losses of the roll (2) and features a device that effects a forced convection on the heating roll (2) when production is interrupted in order to cool the surface to a temperature level that is similar to, or not significantly higher than, in the production state. This device consists of a number of nozzles (4) for applying a cooling medium. <IMAGE>
Patent FI-956235-A0 (FI)
Inventor: TUBA ZOLTAN
IPC: A61K31/58
Filed: 1995-12-22
Abstract: PCT No. PCT/HU93/00040 Sec. 371 Date Dec. 6, 1995 Sec. 102(e) Date Dec. 6, 1995 PCT Filed Jun. 24, 1993 PCT Pub. No. WO95/00532 PCT Pub. Date Jan. 5, 1995The invention relates to novel 4-azaandrostene intermediates of formula (I),    <IMAGE>  (I)  wherein R is hydrogen or a C1-3alkyl group; X is chlorine, bromine or iodine; and the +E,uns ----+EE  bond line is a single or double bond.
Patent FI-960734-A0 (FI)
Inventor: SILLANPAEAE HEIKKI
IPC: E04B2/70
Filed: 1996-02-16
Abstract: Joint structure for joining walls built from logs (1) placed one over the other, said joint structure comprising a post (2) and joint elements in the post and in the log ends for joining them together. The joint elements consist of dovetail joints, by means of which the logs (1) are joined and locked to the post (2). Moreover, the post (2) comprises covering ledges (5) overlapping the sides of the logs.
Patent FI-963393-A0 (FI)
Inventor: DE PLAEN ETIENNE
IPC: C12Q1/68
Filed: 1996-08-30
Abstract: A method for determining cancers is described. The method involves assaying for expression of a gene coding for at least one of MAGE tumor rejection antigen or its precursor expression product.
Patent FI-973805-A0 (FI)
Inventor: SALIN HANNU-PEKKA
IPC: H04W4/16
Filed: 1997-09-26
Abstract: The inventive idea is to set up by parts of forwarded call using services of a closed user group always leg-specifically. Hereby the user group data defined by the subscribers for the leg in question can be used for each leg. The user group data defined by the calling subscriber is used in that leg of the call which is between the calling subscriber and the call forwarding point. User group data defined by the called subscriber who forwarded the call is used between the forwarding point and the subscriber who is the forwarding target.
Patent IL-62981-A0 (IL)
Title: Preparation of concentrated nikkomicin mixtures
IPC: C12P19/38
Filed: 1981-05-28
Abstract: A process for concentrating nikkomicins (X) and (Z) from a dilute impure aqueous solution thereof, comprising contacting the solution with a weakly basic ion exchanger and eluting the adsorbed material with an acid thereby to obtain a concentrated mixture of nikkomicin (X) and nikkomicin (Z). The dilute solution being treated can directly be a filtered microbial cultivation liquor or such a liquor can be prepurified by contact with an acid ion exchanger followed by elution with a base. The recovered material is of relatively high purity.
Patent IL-68282-A0 (IL)
Title: Stable granular formulation of unstable drugs or food supplements and their preparation
IPC: A61K31/70
Filed: 1983-04-01
Abstract: A granulation method involving polysaccharide gelling agents, e.g., alginic acid, and a metal (especially magnesium) salt, oxide or hydroxide, e.g., magnesium hydroxide, is developed for the stabilization of heat- and/or moisture-sensitive drugs or food supplements such as Efrotomycin, avermectins, milbemycins, mocimycin and other drugs. It has been found that the granules so obtained can be incorporated into various formulations without substantial decomposition.
Patent IL-74020-A0 (IL)
Title: Pasteurizable container closure
IPC: B67B3/18
Filed: 1985-01-08
Abstract: A closure for bottles (10) is disclosed which includes an internal radius support disc (48) or cylinder (58) for positioning within the mouth (12) of the bottle to enable the bottle to resist radial inward deformation when subjected to pasteurisation or other post-bottling heat treatment. The closure (40) can be formed by coining a conventional aluminium roll-on cap blank using a pressure block (60) having a central land (64) projectable into the mouth of the bottle to form the support disc or cylinder from the top of the cap blank. Also the cap (50) can be moulded thereby providing a moulded cylinder (58).
Patent IL-79048-A0 (IL)
Title: Joint laxity measurement
IPC: A61B10/00
Filed: 1986-06-06
Abstract: A method for measuring parameters relating to the stability of joints in a patient's body includes the steps of securing a reference portion of the joint (that portion of the joint closest to the body) to a fixed location. A three dimensional digitization of the size, shape, position and coordinate system of the two portions is performed. A soft tissue compensation procedure is performed by applying forces to the reference portion of the joint to thereby determine the amount of reference portion motion, in the soft tissue surrounding the reference portion, due to these forces. A variety of forces are applied to the relative portion of a joint, which is movable relative to the reference portion thereof, and the total motion of the reference and relative portions associated with the forces are measured. By subtracting the motion determined in the soft tissue compensation from motion as determined by applying a variety of forces, the motion of only the relative portion relative to the reference portion is determined.
Patent IL-82091-A0 (IL)
Title: Process for renaturing proteins
IPC: C12N9/04
Filed: 1987-04-02
Abstract: The present invention provides a process for the renaturation of denatured proteins in solution in a renaturation buffer, wherein a solution is prepared of the protein to be renatured in the critical concentration in a selected buffer and, after formation of the folding intermediate, further protein to be renatured is added in the amount necessary for the achievement of the critical concentration.
Patent IL-85494-A0 (IL)
Title: 3-amino-dihydro-(1)-benzopyrans and benzothiopyrans
IPC: A61P25/00
Filed: 1988-02-22
Abstract: Compounds of the formula: <IMAGE> in which Z denotes oxygen or sulphur, R denotes hydrogen or lower alkyl, R1 denotes hydrogen, lower alkyl or aryl-lower alkyl, R2 denotes hydrogen, lower alkyl or aryl-lower alkyl or R1 and R2 together denote alkylene having 4-6 C atoms, R3 denotes hydrogen, hydroxyl, lower alkoxy, aryl-lower alkoxy, acyloxy or aryloxy in compounds having the meaning sulphur for Z, R3 denotes hydroxyl, lower alkoxy, aryl-lower alkoxy, acyloxy or aryloxy in compounds having the meaning oxygen for Z and R3 is bonded in the 5- or 8-position in compounds having the meaning oxygen for Z, R4 and R5 independently of one another denote hydrogen, lower alkyl or halogen, and pharmaceutically acceptable salts thereof and mono- or di-S-oxides of compounds of the formula I in which Z denotes sulphur.   The compounds can be used as modulators for the receptors of the central nervous system, for example as serotonin receptor antagonists in the treatment of disorders of the central nervous system.
Patent SE-8900364-A0 (SE)
Title: Medel för behandling av hypertension
Inventor: KROTKIEWSKI MARCIN
IPC: A61K36/03
Filed: 1989-02-02
Abstract: Medel innehallande kaliumalginat for behandling av hypertension. Alginatet kan fbreligga i form av algfibrer fran brunalger, t.ex. 5 Asophylum nodosum, vilka behandlats med en kaliumforening. Kaliumalginatet kan aven kombineras med vitamin D eller derivat darav, vilket ger en synergistisk effekt. 411 0 6 s 11.0 a go. • • 4sose. 040. .000s. 41110, • • .0 • •• • • • • 1, M BP mm Hg 50 100 15050 100 150 WattWatt PLACEBO AL6neER *** p<0001 vs placebo • 01046 •••• 140 120- 100 '80 *** *** *** MBP ALGF1B-ER 'PLACEBO 10 r 0.730 p < 00O1 • 1234 LI PRA AL6Ft 6Fg. ?)() F 6 3 150 125 120 115 110 105 100 95 90 ABCEWOR 1.1/VD44'0KI\J N6S PEeto 1,aER ***p(0.001 vs period R **p<0.01 vs period R *p<0.05 vs period R F16 UNDERS6KNIN4,5PeR10bER "*p<0.00 I vs period R p<0.0 1 vs period R G. tjj 3,5 2 =t 5,0 .tr 4: 2,5 0 2.0 1,5- 1,0 0,5 - 0,0 8 UNDE42S6KiJiNCI.&PE.Ricberz. *p<0.001 4.r)<0.05 0 1140, 0 m1,04 4444 1404 " 4 3 0 0 4 44 e, 40 ' 4.4 4.'. "
Patent FI-20050878-A0 (FI)
IPC: B66F9/24
Filed: 2005-09-06
Abstract: Load handling apparatus and method for handling loads, like paper rolls or household appliances, wherein the load handling apparatus comprises a vehicle (1) with a hydraulic system (76) controlled by an electronic control system (77), a lifting means (1), a hydraulics user interface (78) for the operator and a gripper arranged in the vehicle's lifting means (11) and provided with arms (6, 7) capable of clamping and lifting a load by applying a compressive force to the load, wherein the gripper is provided with an electric or electronic control system (80), and wherein the gripper's control system is directly connected to the vehicle's hydraulics control system (77) or hydraulics user interface (79) through an electronic interface (73, 90) so that the gripper's control system is capable of controlling the vehicle's hydraulic functions in a similar way as the vehicle's operator using the vehicle's hydraulics user interface (78).
Patent IL-102597-A0 (IL)
Title: Pleuromutilin complexes,their preparation and pharmaceutical compositions containing them
IPC: A61K31/724
Filed: 1992-07-22
Abstract: Complexes and pharmaceutical preparations containing complexes of the pleuromutilin derivative of formula I <CHEM> in free base or in acid addition or quaternary salt form and cyclodextrin are described. They can be prepared by complexing the above pleuromutilin compound with an appropriate cyclodextrin. They are indicated for use as pharmaceuticals, e.g. as antibiotics, especially in veterinary medicine, e.g. as feed additives.
Patent IL-108229-A0 (IL)
Title: Arylsulfonamido-substituted hydroxamic acid
IPC: C07D261/10
Filed: 1993-12-30
Abstract: Compounds of formula I <CHEM> wherein R, R1, R2 and Ar are as defined in the description, have valuable pharmaceutical properties and are effective especially as matrix metalloproteinase inhibitors, for example for the treatment of arthritis. They are prepared in a manner known per se.
Patent IL-111164-A0 (IL)
Title: Device for determining the effect of pulsed magnetic fields on an organism
IPC: A61N2/02
Filed: 1994-10-04
Abstract: PCT No. PCT/EP94/03325 Sec. 371 Date Jun. 11, 1996 Sec. 102(e) Date Jun. 11, 1996 PCT Filed Oct. 8, 1994 PCT Pub. No. WO95/10228 PCT Pub. Date Apr. 20, 1995A device for determining the effect of pulsed primary magnetic fields on an organism has a measuring pick-up for secondary magnetic field signals generated by the organism in response to the primary magnetic fields. An evaluation circuit for the secondary magnetic field signals is provided. The evaluation circuit has a first memory device with a memory unit. The evaluation circuit has a control device. The control device includes a device for processing sequential secondary magnetic field signals such that the sequential secondary magnetic field signals are combined to a cumulative signal in the memory unit. The cumulative signal is used as an output signal of the evaluation circuit.
Patent IL-112157-A0 (IL)
Title: Improved method for the preparation of pyridine-2,3-dicarboxylic acids
IPC: C07D213/80
Filed: 1994-12-27
Abstract: The present invention provides an improved method for the preparation of pyridine-2,3-dicarboxylic acids of formula (I) by the continuous oxidation of substituted quinolines of formula (II). <CHEM>
Patent IL-130363-A0 (IL)
Title: Farnesyltransferase inhibiting quinazolinones
IPC: A61P35/00
Filed: 1998-04-17
Abstract: This invention concerns compounds of formulathe pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein the dotted line represents an optional bond; X is oxygen or sulfur; R1 and R2 each independently are hydrogen, hydroxy, halo, cyano, C1-6alkyl, trihalomethyl, trihalomethoxy, C2-6alkenyl, C1-6alkyloxy, hydroxyC1-6alkyloxy, C1-6alkyloxyC1-6alkyloxy, C1-6alkyloxycarbonyl, aminoC1-6alkyloxy, mono- or di(C1-6alkyl)aminoC1-6alkyloxy, Ar1, Ar1C1-6alkyl, Ar1oxy, Ar1C1-6alkyloxy; or when on adjacent positions R1 and R2 taken together may form a bivalent radical; R3 and R4 each independently are hydrogen, halo, cyano, C1-6alkyl, C1-6alkyloxy, Ar1oxy, C1-6alkylthio, di(C1-6alkyl)amino, trihalomethyl, trihalomethoxy; R5 is hydrogen, halo, cyano, optionally substituted C1-6alkyl, C1-6alkyloxycarbonyl or Ar1; or a radical of formula -OR10, -SR10, -NR11R12; R6 is an optionally substituted imidazolyl moiety; R7 is hydrogen or C1-6alkyl provided that the dotted line does not represent a bond; R8 is hydrogen, C1-6alkyl or Ar2CH2 or Het1CH2; R9 is hydrogen, C1-6alkyl, C1-6alkyloxy or halo, or R8 and R9 taken together may form a bivalent radical; Ar1 and Ar2 are optionally substituted phenyl and Het1 is optionally substituted pyridinyl; having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
Patent IL-133825-A0 (IL)
Title: Substituted 6-phenylphenanthridines, medicaments containing same and use thereof
IPC: A61P13/12
Filed: 1998-07-18
Abstract: PCT No. PCT/EP98/04478 Sec. 371 Date Jan. 24, 2000 Sec. 102(e) Date Jan. 24, 2000 PCT Filed Jul. 18, 1998 PCT Pub. No. WO99/05113 PCT Pub. Date Feb. 4, 1999The invention relates to compounds of formula (I): wherein R1, R2, R3, R31, R4, R5, R51 and R6 are as defined in the specification. The compounds are phosphodiesterase inhibitors. Also disclosed are pharmaceutical compositions and methods of use of the compounds.
Patent IL-136697-A0 (IL)
Title: Method and apparatus for cleaning poultry
IPC: A23B4/02
Filed: 1998-12-11
Abstract: An apparatus used for reducing the amount of pathogenic bacteria associated with a bird or other edible animal, and preferably chickens, comprising: (a) a unit having an interior portion having side and bottom walls, an exterior portion having side and bottom walls and end walls connecting said interior portion to said exterior portion wherein the area of said interior portion provides a space which completely surrounds one or more of the birds or animals being treated; (b) one or more flood nozzles mounted within said interior portion of said unit and connected to a source of a bacteria reducing chemical solution to enable the bacteria reducing chemical solution to be applied to the entire interior of the body cavity of the bird or animal being treated; (c) one or more spray nozzles mounted within said interior portion of said unit and connected to a source of a bacteria reducing chemical solution to enable the bacteria reducing chemical solution to be applied to the entire external surfaces of the bird or animal being treated; and (d) one or more lines for connecting said one or more flood nozzles and said one or more spray nozzles to the source of the bacteria reducing chemical solution.
Patent IL-141645-A0 (IL)
Title: Use of methoxymorpholino doxorubicin for the treatment of a liver tumor
IPC: A61K31/7052
Filed: 1999-08-27
Abstract: The present invention relates to the use of methoxymorpholino doxorubicin for the treatment of a liver cancer; in particular, it refers to the intrahepatic administration of methoxymorpholino doxorubicin for use in the liver tumor therapy optionally in association with an agent which remains selectively in liver tumor after its injection through the hepatic artery.
Patent IL-143977-A0 (IL)
Title: Crystalline bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulphonyl) amino] pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid] calcium salt
IPC: A61P43/00
Filed: 1999-12-23
Abstract: The present invention relates to a crystalline form of the compound bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S)-3, 5-dihydroxyhept-6-enoic acid]calcium salt, as well as processes for its manufacture and pharmaceutical compositions comprising the crystalline form, which is useful as an agent for treating hyperlipidemia, hypercholesterolemia and atherosclerosis.